Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial.
de Fijter JW, Holdaas H, Øyen O, Sanders JS, Sundar S, Bemelman FJ, Sommerer C, Pascual J, Avihingsanon Y, Pongskul C, Oppenheimer F, Toselli L, Russ G, Wang Z, Lopez P, Kochuparampil J, Cruzado JM, van der Giet M; ELEVATE Study Group. de Fijter JW, et al. Among authors: oyen o. Am J Transplant. 2017 Jul;17(7):1853-1867. doi: 10.1111/ajt.14186. Epub 2017 Feb 14. Am J Transplant. 2017. PMID: 28027625 Free article. Clinical Trial.
Chronic allograft nephropathy--a clinical syndrome: early detection and the potential role of proliferation signal inhibitors.
Campistol JM, Boletis IN, Dantal J, de Fijter JW, Hertig A, Neumayer HH, Oyen O, Pascual J, Pohanka E, Ruiz JC, Scolari MP, Stefoni S, Serón D, Sparacino V, Arns W, Chapman JR. Campistol JM, et al. Among authors: oyen o. Clin Transplant. 2009 Nov-Dec;23(6):769-77. doi: 10.1111/j.1399-0012.2009.01057.x. Epub 2009 Aug 27. Clin Transplant. 2009. PMID: 19719730 Review.
Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance.
Campistol JM, Albanell J, Arns W, Boletis I, Dantal J, de Fijter JW, Mortensen SA, Neumayer HH, Øyen O, Pascual J, Pohanka E, Schena FP, Serón D, Sparacino V, Chapman JR. Campistol JM, et al. Among authors: oyen o. Nephrol Dial Transplant. 2007 May;22 Suppl 1:i36-41. doi: 10.1093/ndt/gfm090. Nephrol Dial Transplant. 2007. PMID: 17456617 Review.
Early versus late acute antibody-mediated rejection in renal transplant recipients.
Dörje C, Midtvedt K, Holdaas H, Naper C, Strøm EH, Øyen O, Leivestad T, Aronsen T, Jenssen T, Flaa-Johnsen L, Lindahl JP, Hartmann A, Reisæter AV. Dörje C, et al. Among authors: oyen o. Transplantation. 2013 Jul 15;96(1):79-84. doi: 10.1097/TP.0b013e31829434d4. Transplantation. 2013. PMID: 23632391
Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation.
Lindahl JP, Massey RJ, Hartmann A, Aakhus S, Endresen K, Günther A, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T. Lindahl JP, et al. Among authors: oyen o. Transplantation. 2017 Jun;101(6):1261-1267. doi: 10.1097/TP.0000000000001274. Transplantation. 2017. PMID: 27467687
120 results